51.0 C-
GHK
Also known as: Gly-His-Lys
Emerging Research Research Chemical
Research Evidence 22.0/100
Safety Profile 80.0/100
9 Clinical Trials
Unknown: 1 PHASE4: 1 PHASE1: 1 NA: 6
- Amino Acids Expression Profiling of Patients With Sepsis Unknown Phase UNKNOWN Chinese PLA General Hospital
- Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy PHASE4 COMPLETED University of Ioannina
- Study of QRH-882260 Heptapeptide Application in the Colon PHASE1 TERMINATED Danielle Kim Turgeon
- Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery. NA RECRUITING National Institute of Cancerología
- Generation Healthy Kids: A Cluster-randomized Trial of a Multi-component, Multi-setting Intervention NA COMPLETED University of Copenhagen
Showing 5 of 9 trials.
16 Research Papers
- Anxiolytic Effect of GHK-PGP Peptide and Its Structural Analogues in a Test with Punished Behavior. Bull Exp Biol Med unknown
- Design, synthesis and applications of a dual-mode peptidyl probe for sequential determination of Cu(2+) and S(2-) in food and biological systems. Spectrochim Acta A Mol Biomol Spectrosc unknown
- Generation Healthy Kids: a protocol for the mixed methods process evaluation of a school- and community-based intervention targeting healthy weight and wellbeing among 6-11-year-olds in Denmark. Trials unknown
- Carbonless amino acids and a carbonless GHK peptide. Phys Chem Chem Phys unknown
- Elastic cationic liposomal nanogels: a novel platform for topical nicotinamide mononucleotide delivery. J Liposome Res unknown
Showing 5 of 16 papers by citation count.
FDA Data
Not FDA-Approved
GHK has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
Frequently Asked Questions
Is GHK FDA approved?
No, GHK has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has GHK been studied in?
GHK has been studied in 9 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for GHK?
GHK has a CheckPeptides trust score of 51.0/100 (grade: C-). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026
Quick Facts
- Classification
- Tripeptide growth factor carrier
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 22.0/100
Safety Profile 80.0/100
Evidence Summary
- Clinical Trials
- 9
- Research Papers
- 16
- Trust Score
- 51.0/100
- Grade
- C-